Clinical trial
Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age
NCT00174460 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00174460 |
|---|---|
| Title | Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age |
| Official title | Somatropin Therapy For Short Children Born Of Premature Gestation, A Controlled, Prospective Randomized, Multicenter Study With An Untreated Control Group. |
| Acronym | AGA |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Growth Hormone Therapy, Infant, Very Low Birth Weight |
| Intervention type | Drug, Other |
| Interventions | Somatropin, Control Arm |
| Enrollment | 33 |
| Start date | Aug 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2010 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 5, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: